Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Gets Second EUA, For Baricitinib In COVID-19 Patients

Nov 20 2020

• By Joseph Haas

Coronavirus globe — Lilly's second EUA for a COVID-19 therapy covers Olumiant in hospitalized patients

Related Content

Lilly’s Olumiant Could Get Blood Clot Redemption With EUA For COVID

Sep 15 2020

Coronavirus Update: Lilly To Seek EUA For Olumiant

Oct 09 2020

Positive Atopic Dermatitis Data On Lilly's Newly-Approved Olumiant

Nov 02 2020

Lilly’s Olumiant Cuts COVID-19 Hospital Stays By One Day

Sep 14 2020

Related Companies

Eli Lilly and Company

Gilead Sciences, Inc.

Incyte Corporation

Additional Topics

Coronavirus COVID-19 Approvals BioPharmaceutical

More from COVID-19

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window